W.H.O. Rejects Antiviral Drug Remdesivir as a Covid Treatment
Published
In a review of several trials, the World Health Organization found that Gilead’s drug did not improve survival rates for patients nor did it help them recover.
Full ArticlePublished
In a review of several trials, the World Health Organization found that Gilead’s drug did not improve survival rates for patients nor did it help them recover.
Full ArticleWASHINGTON (AP) — The coronavirus vaccine inching toward approval in the U.S. is desperately anticipated by weary Americans..
BetterLife Pharma Inc (CSE:BETR) (OTCQB:BETRF) (FRA:NPAU), a biotech company focused on interferon (IFN) based therapeutics,..
The antiviral drug remdesivir should not be used as a routine treatment for COVID-19 patients in critical care wards, the head of..